04/11/2024
Excited to chair the online discussion with IAS members from Africa discussing the latest HIV injectable treatment "Lenacapavir : Recent results in HIV prevention".
Lenacapavir was recently tested in Africa as an injection for prevention of HIV and proved that 99,9% of people who used Lenacapavir were not acquiring HIV(WHO Sept 2024) .
As a treatment option,people living with HIV taking Lenacapavir had their viral load suppressed within 52 weeks.
Treatment and prevention towards the goal of ending AIDS by 2030.